drugset
Drugs / Tetravalent Dengue Vaccine
last change Dec 2013 re-read 3 minutes ago

Tetravalent Dengue Vaccine

also known as TVDV

Vaccine

Developed for
dengue disease
Investigated by
Naval Medical Research Center · U.S. Army Medical Research and Development Command · Vical · Walter Reed Army Institute of Research (WRAIR)

Trials 1

today NCT01502358 · Ph 1
2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01502358 Dec 2011 → Dec 2013 dengue disease U.S. Army Medical Research and Development Command Completed No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Tetravalent Dengue Vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT01502358 ↗
Known as TVDV “Tetravalent Dengue Vaccine (TVDV)” NCT01502358 ↗
Modality Vaccine “Plasmid DNA Vaccine” NCT01502358 ↗
Route Intramuscular “Low dose delivered intramuscularly on Study Days 0, 30 and 90” NCT01502358 ↗